Pyoderma gangrenosum complicating Cogan's syndrome

Clinical and Experimental Dermatology

Volumn 23, Issue 6, 1998, Pages 286-289

  Boulinguez, S ^a   Bernard, P ^b   Bedane, C ^a   Lasudry, J ^a   Labrousse, F ^a   Bonnetblanc, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CLINICAL FEATURE; COGAN SYNDROME; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SLIT LAMP; TREATMENT OUTCOME; UVEITIS;

EID: 0032421686     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1998.00390.x     Document Type: Article

References (16)

1. 1. Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophtal 1945; 33: 144.
2. 2. Vinceneux P, Pouchot J. Syndrome de Cogan. In: Kahn MF, Peltiev AP, Meyer O, Piette JC, eds. Maladies Systémiques, 3rd edn. Paris: Médecine-Sciences Flammarion, 1991: 753-61.
3. 3. Vollerstern RS, McDonald JJ, Younge BR et al. Cogan's syndrome: 18 cases and review of the literature. Mayo Clin Proc 1986; 61: 344-61.
4. 4. Mogan RF, Baumgartner CJ. Meniere's disease complicated by recurrent interstitial keratitis: excellent results following cervical ganglionectomy. West J Surg 1934; 42: 628-631.
5. 5. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (ecthyma) gangrenosum: clinical and experímental observations in five cases occurring in adults. Arch Dermatol 1930; 22: 655-80.
6. 6. Vignon-Pennamen MD, Wallach D. Cutaneous manifestations of neutrophilic disease: a study of seven cases. Dermatologica 1991; 183: 255-64.
7. 7. Haynes BF, Kaiser-Kupfer MI, Mason P et al. Cogan syndrome: studies on thirteen patients, longterm follow-up, and a review of the literature. Medicine 1980; 59: 426-41.
8. 8. Bodemer C, Teillac-Hamel D, Virelizier et al. Syndrome de Cogan. Ann Dermatol Vénéréol 1984; 111: 673-4.
9. 9. Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
10. 10. Bertram-Callens C, Machet L, Vaillant L et al. Localisations buccales et oculaires de pyoderma gangrenosum au cours d'une maladie de Vaquez. Ann Dermatol Vénéréol 1991; 118: 611-4.
11. 11. Poskitt L, Burge S. Pyoderma gangrenosum associated with IgA paraproteinaemia and ocular vasculitis. Br J Dermatol 1994; 131: 919-20.
12. 12. Babe KS, Gross AS, Leyna WH, King LE. Pyoderma gangrenosum associated with antiphospholipid antibodies. Int J Dermatol 1992; 31: 588-90.
13. 13. Berth-Jones J, Tan SV, Graham-Brown RAC, Pembroke AC. The successful use of minocyline in pyoderma gangreuosum. A report of seven cases and review of the literature. J Dermatol Treat 1989; 1: 23-5.
14. 14. Mutalik S, Gharpuray MB. Minocycline in pyoderma gangrenosum. J Dermatol Treat 1992; 3: 160.
15. 15. Martin RR, Warr G, Yeager H et al. The effects of tetracycline on leucotaxis. J Infect Dis 1974; 129: 110-6.
16. 16. Bernard P, Amici JM, Catanzano G et al. Pyoderma propos de 3 observations. Ann Dermatol Vénéréol 1229 34; 1987: 114.